Literature DB >> 6338388

Memory enhancement with oral physostigmine in Alzheimer's disease.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6338388     DOI： 10.1056/NEJM198303243081212

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Cholinergic system and constructional praxis: a further study of physostigmine in Alzheimer's disease.

Authors:  O Muramoto; M Sugishita; K Ando
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-05       Impact factor: 10.154

2.  Drug-induced purposeless chewing: animal model of dyskinesia or nausea?

Authors:  N M Rupniak; S J Tye; S D Iversen
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Efficacy of oral physostigmine in primary degenerative dementia. A double-blind study of response to different dose level.

Authors:  S A Beller; J E Overall; A C Swann
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.